MAD2L1 and ovarian cancer: We conclude that the most aggressive ovarian cancer type in vivo, HGSC, is marked by higher expression of Mad2 and lower expression of miR-493-3p in comparison to non-malignant tissue, and that miR-493-3p and Mad2 levels inversely correlate in ovarian cell lines.